This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Adults aged more than 70 who received more prescriptions for nirmatrelvir-ritonavir did not show decreased rates of COVID-19–related hospital admissions or deaths.
Medscape Medical News